<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Interactive diabetes case 16: A 61-year-old patient with uncontrolled type 2 diabetes on two oral agents – A4
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Interactive diabetes case 16: A 61-year-old patient with uncontrolled type 2 diabetes on two oral agents – A4
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Interactive diabetes case 16: A 61-year-old patient with uncontrolled type 2 diabetes on two oral agents – A4
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lloyd Axelrod, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 21, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          ANSWER
         </span>
         <span class="headingEndMark">
          —
         </span>
         Incorrect.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10327" href="/z/d/drug information/10327.html" rel="external">
          Pramlintide
         </a>
         is a synthetic analogue of amylin.
        </p>
        <p>
         Amylin is co-secreted with insulin from the beta cells of the pancreatic islets. Amylin molecules aggregate and form amyloid fibers. Amyloid deposits composed of amylin are present in beta cells (hence the name amylin) and may contribute to the pathogenesis of diabetes. Like insulin, secretion is deficient in patients with diabetes. Like glucagon-like peptide 1 (GLP-1) receptor agonists, amylin inhibits glucagon secretion, delays gastric emptying, and promotes satiety. However, it does not stimulate insulin secretion. (See
         <a class="medical medical_review" href="/z/d/html/1758.html" rel="external">
          "Amylin analogs for the treatment of diabetes mellitus", section on 'Pramlintide'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10327" href="/z/d/drug information/10327.html" rel="external">
          Pramlintide
         </a>
         is a stable analogue of amylin with similar pharmacologic properties but without the potential for aggregation.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10327" href="/z/d/drug information/10327.html" rel="external">
          Pramlintide
         </a>
         is approved for use in patients with type 1 and type 2 diabetes who are treated with insulin but are not meeting glycemic goals. Pramlintide cannot be mixed with insulin in the same syringe. Thus, the patient on pramlintide must inject pramlintide three times a day before each meal and also inject insulin separately.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10327" href="/z/d/drug information/10327.html" rel="external">
          Pramlintide
         </a>
         may cause hypoglycemia, especially in patients with type 1 diabetes. It causes nausea in approximately 30 percent of patients, reduces the glycated hemoglobin (A1C) value by only 0.5 to 0.7 percent, and is expensive. It produces modest weight loss, due at least in part to the gastrointestinal (GI) side effects. It is contraindicated in patients with gastroparesis. There is limited long-term experience with this agent.
        </p>
        <p>
         <a class="drug drug_general" data-topicid="10327" href="/z/d/drug information/10327.html" rel="external">
          Pramlintide
         </a>
         is not an appropriate therapy for the patient under consideration, because the patient is not taking insulin. It cannot be recommended, in general, for patients on insulin because of the considerations noted in the previous two paragraphs.
        </p>
        <p>
         Return to the beginning to try again. (See
         <a class="medical medical_review" href="/z/d/html/4176.html" rel="external">
          "Interactive diabetes case 16: A 61-year-old patient with uncontrolled type 2 diabetes on two oral agents"
         </a>
         .)
        </p>
       </div>
       <div id="topicVersionRevision">
        Topic 4213 Version 7.0
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
